Материалы

20.09.2022

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis

Dimitrios Velissaris , Nicholas Zareifopoulos , Vasileios Karamouzos , Evangelos Karanikolas , Charalampos Pierrakos , Ioanna Koniari , Menelaos Karanikolas 1. Department of Internal Medicine, General University Hospital of Patras, Patras, GRC 2.

Department of Psychiatry, General Hospital of Nikaia, Piraeus "Agios Panteleimon", Athens, GRC 3. Department of Internal Medicine, University of Patras School of Health Sciences, Patras, GRC 4. Intensive Care Unit, General University Hospital of Patras, Patras, GRC 5. Department of Internal Medicine, University of Patras, Patras, GRC 6. Intensive Care Unit, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, BEL 7. Department of Electrophysiology and Device, University Hospital of South Manchester NHS Foundation Trust, Manchester, GBR 8.

Department of Anesthesiology, Washington University School of Medicine, St. Louis, USA Corresponding author: Nicholas Zareifopoulos, nizareifopoulos@gmail.com
03.06.2022

Пресепсин для диагностики раннего неонатального сепсиса: систематический обзор и мета-анализ

Poggi C, Lucenteforte E, Petri D, De Masi S, Dani C.
Presepsin for the Diagnosis of Neonatal Early-Onset Sepsis: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022 May 31. doi: 10.1001/jamapediatrics.2022.1647

01.06.2022

Presepsin: Hope in the Quest for the Holy Grail

Abhishek Samprathi1, Madhusudan Samprathi2, Mounika Reddy3

1 Department of Critical Care Medicine, Fortis Hospitals, Bengaluru, Karnataka, India
2,3 Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India

Corresponding Author: Madhusudan Samprathi, Department of Pediatrics, All India Institute of Medical Sciences, Hyderabad, Telangana, India, Phone: +917077703235, e-mail: madhu_1511@yahoo.com

14.05.2022

Perinatal presepsin assessment: a new sepsis diagnostic tool?

Valentina Botondi, Ebe D’Adamo, Mario Plebani, Oriana Trubiani, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante, Maria Chiara Strozzi, Antonio Maconi, Francesca Gazzolo, Marta Betti, Annalisa Roveta, Gabriella Levantini and Diego Gazzolo*

Valentina Botondi, Ebe D’Adamo, Marika Perrotta, Laura Di Ricco, Cynzia Spagnuolo, Sara De Sanctis, Elisabetta Barbante and Gabriella Levantini, Neonatal Intensive Care Unit, G. D’Annunzio University, Chieti, Italy

Mario Plebani, Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy. https://orcid.org/0000-0002-0270-1711

Oriana Trubiani, Department of Innovative Technologies in Medicine & Dentistry, University “G. D’Annunzio”, Chieti, Italy

Maria Chiara Strozzi, Antonio Maconi, Marta Betti and Annalisa Roveta, AO SS Antonio, Biagio and C. Arrigo Hospital, Alessandria, Italy. https://orcid.org/0000-0002-1904-7277 (A. Roveta)

Francesca Gazzolo, Magna Graecia University, Catanzaro, Italy

*Corresponding author: Prof. Diego Gazzolo, Neonatal Intensive Care Unit, G. D’Annunzio University, 65100 Chieti, Italy, Phone: +39 0871 358219, E-mail: dgazzolo@hotmail.com 

25.04.2022

Пресепсин в диагностике нозокомиальной инфекции центральной нервной системы

С.А. Абудеев1, К.В. Киселев2, О.В. Паринов1, Ю.Д. Удалов1, М.В. Забелин1, А.С. Самойлов1, К.А. Попугаев1*

Отделение нейрореанимации и нейроанестезиологии

1 ФГБУ «ГНЦ — ФМБЦ имени А.И. Бурназяна» ФМБА,
Российская Федерация, 123098 Москва, ул. Маршала Новикова, д. 23
2 ГБОУ ВО «РНИМУ имени Н.И. Пирогова» Минздрава России, Российская Федерация, 117997 Москва, ул. Островитянова, д. 1

* Контактная информация: Попугаев Константин Александрович, доктор медицинских наук, заведующий отделением нейрореанимации ФГБУ ГНЦ ФМБЦ А.И. Бурназяна ФМБА России. E-mail: stan.popugaev@yahoo.com

11.04.2022

Biomarkers of Neonatal Sepsis: From Being Mere Numbers to Becoming Guiding Diagnostics

Sai Sravya Gude 1, Nikhil Chowdary Peddi 2, Sravya Vuppalapati 2, Shravya Venu Gopal 3, Harshita Marasandra Ramesh 4, Sai Sreeya Gude 5

1 Pediatrics, Guntur Medical College, Guntur, IND
2 Pediatrics, PES Institute of Medical Sciences and Research, Kuppam,IND
3 InternalMedicine,KasturbaMedicalCollegeMangalore,Mangalore,IND
4 InternalMedicineand Pediatrics, Kasturba Medical College Mangalore, Mangalore, IND
5 Internal Medicine, Guntur Medical College, Guntur, IND

Corresponding author: Nikhil Chowdary Peddi, nikhilchowdarypeddi@gmail.com

23.02.2022

Биомаркеры инфекции в оптимизации антибактериальной терапии: оправданные ожидания

Кулабухов В.В.1, Шабанов А.К.1, Андреева И.В.2, Стецюк О.У.2, Андреев В.А.3

1 НИИ скорой помощи им. Н.В. Склифосовского, Москва, Россия
2 НИИ антимикробной химиотерапии ФГБОУ ВО СГМУ Минздрава России, Смоленск, Россия
3 ФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России, Смоленск, Россия

Контактный адрес: Ирина Вениаминовна Андреева, E-mail: Irina.Andreeva@antibiotic.ru

13.11.2021

The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review

Chiara Maddaloni 1, Domenico Umberto De Rose 1 , Alessandra Santisi 1, Ludovica Martini 1, Stefano Caoci 1, Iliana Bersani 1, Maria Paola Ronchetti 1,2 and Cinzia Auriti 1,*,†

1 Neonatal Intensive Care Unit (NICU), Medical and Surgical Department of the Fetus—Newborn-Infant, “Bambino Gesù” Children’s Hospital IRCCS, 00165 Rome, Italy; chiara.maddaloni@opbg.net (C.M.); domenico.derose@opbg.net (D.U.D.R.); alessandra.santisi@opbg.net (A.S.); ludovica.martini@opbg.net (L.M.); stefano.caoci@opbg.net (S.C.); iliana.bersani@opbg.net (I.B.); mariapaola.ronchetti@opbg.net (M.P.R.)

2 Neonatal Intensive Care (NICU) and Neonatal Pathology, San Vincenzo Hospital, 98039 Taormina, Italy

Correspondence: cinzia.auriti@opbg.net; Tel.: +39-06-6859-2427; Fax: +39-06-6859-3916
On behalf of the Study Group of Neonatal Infectious Diseases of the Italian Society of Neonatology (SIN)

10.10.2021

Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review

Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzoet al.

1 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.); marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.); marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)

2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy;
tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)

* Correspondence: michelecosimo.santoro@policlinicogemelli.it
02.09.2021

Presepsin as a Predictive Biomarker of Severity in COVID-19: A Systematic Review

Sibtain Ahmed1, Maheen Mansoor2, Muhammad S Shaikh3, Imran Siddiqui4

1,3,4 Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
2 Department of Medical College, Aga Khan University, Karachi, Pakistan

Corresponding Author: Sibtain Ahmed, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan, e-mail: sibtain.ahmed@aku.edu
11.08.2021

The Role and Validity of Diagnostic Biomarkers in Late-Onset Neonatal Sepsis

Patience Mwesigye1, Fizza Rizwan2, Niazy Alassaf3, Rizwan Khan3

1 InternalMedicine,UniversityofLimerick,Limerick,IRL
2 InternalMedicine,MedicalUniversityofSofia,Sofia,BGR
3 Neonatology, University Maternity Hospital, Limerick, Limerick, IRL

Corresponding author: Patience Mwesigye, patiencehonors@gmail.com
30.07.2021

Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review

Andrea Piccioni1, Michele Cosimo Santoro1,*, Tommaso de Cunzo2, Gianluca Tullo2, Sara Cicchinelli1, Angela Saviano2, Federico Valletta2, Marco Maria Pascale1, Marcello Candelli1, Marcello Covino1,2 and Francesco Franceschi1,2

1 Emergency Medicine Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy; andrea.piccioni@policlinicogemelli.it (A.P.); sara.cicchinelli@policlinicogemelli.it (S.C.);
marcomaria.pascale@policlinicogemelli.it (M.M.P.); marcello.candelli@policlinicogemelli.it (M.C.);
marcello.covino@policlinicogemelli.it (M.C.); francesco.franceschi@policlinicogemelli.it (F.F.)

2 Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; tomdecunzo@gmail.com (T.d.C.); gianlucatullo@gmail.com (G.T.); saviange@libero.it (A.S.); fede.valletta@gemelli.com (F.V.)

*Correspondence: michelecosimo.santoro@policlinicogemelli.it
19.05.2021

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis

Dimitrios Velissaris1, Nicholas Zareifopoulos2, 3, Vasileios Karamouzos4, Evangelos Karanikolas5, Charalampos Pierrakos6, Ioanna Koniari7, Menelaos Karanikolas8

1 Department of Internal Medicine, General University Hospital of Patras, Patras, GRC
2 Department of Psychiatry, General Hospital of Nikaia, Piraeus "Agios Panteleimon", Athens, GRC 3Department of Internal Medicine, University of Patras School of Health Sciences, Patras, GRC
4 Intensive Care Unit, General University Hospital of Patras, Patras, GRC
5 Department of Internal Medicine, University of Patras, Patras, GRC
6 Intensive Care Unit, Brugmann University Hospital, Université Libre de Bruxelles, Brussels, BEL
7 Department of Electrophysiology and Device, University Hospital of South Manchester NHS Foundation Trust, Manchester, GBR
8 Department of Anesthesiology, Washington University School of Medicine, St. Louis, USA

Corresponding author: Nicholas Zareifopoulos, nizareifopoulos@gmail.com

19.03.2021

Novel Diagnostics and Therapeutics in Sepsis

Kieran Leong 1, Bhavita Gaglani 2 , Ashish K. Khanna 2,3, Michael T. McCurdy 1,*

1 Division of Pulmonary & Critical Care, University of Maryland School of Medicine, Baltimore, MD 21201, USA; kleong@som.umaryland.edu
2 Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest University Hospital, Winston-Salem, NC 27157, USA; bgaglani@wakehealth.edu (B.G.); ashish@or.org (A.K.K.)
3 Department of Outcomes Research, Outcomes Research Consortium, Cleveland, OH 44195, USA
* Correspondence: drmccurdy@gmail.com
27.01.2021

Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis

Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,
Chih‑Huang Li3, Gerald N. Blaney III1, Zhen‑Ying Liu1 and Kuan‑Fu Chen1,3,6,7*

*Correspondence: drkfchen@gmail.com
6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
27.01.2021

Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines

Alice Nicoleta Dragoescu 1, Vlad Padureanu 2,* , Andreea Doriana Stanculescu 1,*, Luminit,a Cristina Chiut,u 1,
Dan Nicolae Florescu 3, Ioana Andreea Gheonea 4, Rodica Padureanu 5 , Alex Stepan 6, Costin Teodor Streba 7,
Andrei Ioan Drocas,
8, Adriana Mihaela Ciocâlteu-Ionescu 3, Valeriu MarinS,
urlin 9 and Octavian
Petru Dragoescu 8


1 Department of Anesthesiology and Intensive Care, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; alice.dragoescu@yahoo.com (A.N.D.); luminita.chiutu@gmail.com (L.C.C.)
2 Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
3 Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
nicku_dan@yahoo.co.uk (D.N.F.); adriana_ciocalteu@yahoo.com (A.M.C.-I.)
4 Department of Radiology and Medical Imaging, University of Medicine and Pharmacy of Craiova, 200349
Craiova, Romania; iagheonea@gmail.com
5 Department of Biochemistry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
zegheanurodica@yahoo.com
6 Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
astepan76@yahoo.com
7 Department of Research Methodology, University of Medicine and Pharmacy of Craiova, 200349 Craiova,
Romania; costinstreba@gmail.com
8 Department of Urology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania;
andrei_drocas@yahoo.com (A.I.D.); pdragoescu@yahoo.com (O.P.D.)
9 Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania;
vsurlin@gmail.com
* Correspondence: vldpadureanu@yahoo.com (V.P.); stanculescu.andreea@yahoo.com (A.D.S.)
27.01.2021

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis

Yutaka Kondo1†, Yutaka Umemura2†, Kei Hayashida3†, Yoshitaka Hara4, Morio Aihara5 and Kazuma Yamakawa6

†Yutaka Kondo, Yutaka Umemura and Kei Hayashida contributed equally to
this work.
6Division of Trauma and Surgical Critical Care, Osaka General Medical Center,
3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan
Full list of author information is available at the end of the article
27.01.2021

Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C‑reactive protein: a systematic review and meta‑analysis

Chin‑Chieh Wu1, Hao‑Min Lan2, Shih‑Tsung Han3, Chung‑Hsien Chaou3, Chun‑Fu Yeh4, Su‑Hsun Liu2,5,
Chih‑Huang Li3, Gerald N. Blaney III1, Zhen‑Ying Liu1 and Kuan‑Fu Chen1,3,6,7

*Correspondence: drkfchen@gmail.com
6 Clinical Informatics and Medical Statistics Research Center, Chang Gung
University, 5 Fu‑Shin Street, Gueishan Village, Taoyuan 333, Taiwan
Full list of author information is available at the end of the article
27.01.2021

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis

Ying Zhu1,2
Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
Tianzhu Tao4

1Department of Respiratory Medicine,
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Republic of China; 2Department of
Respiratory and Critical Care Medicine,
Shanghai East Hospital, Tongji University,
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic of
China; 4Department of Anesthesiology,
Air Force Medical Center, PLA, Beijing,
People’s Republic of China
28.09.2020

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1*

1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
28.09.2020

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli



29.07.2020

Presepsin as a biomarker in perioperative medicine

Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,
Simonetta TESORO 3, Edoardo DE ROBERTIS 3

1Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany; 2Department of Medicine
and Surgery, University of Salerno, Baronissi, Salerno, Italy; 3Department of Surgical and Biomedical Sciences,
University of Perugia, Perugia, Italy
02.07.2020

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1*

* Correspondence: JGAHN@yuhs.ac
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
02.07.2020

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli
14.04.2020

Анализатор PATHFAST: Диагностика и мониторинг осложнений, связанных с инфекцией COVID-19

07.04.2020

Лабораторные нарушения у пациентов с инфекцией COVID-2019

Giuseppe Lippi/ Марио Плебани Опубликовано: 2020-03-03 J Clin Chem Lab Med / DOI: https://doi.org/10.1515/cclm-2020-0198
07.04.2020

Кампания Выживем При Сепсисе: Руководство по ведению критически больных взрослых с коронавирусной болезнью 2019 (COVID-19)

Перевод В.С. Гороховского, М.Б. Куцего, А.А. Науменко, В.Д. Охотника, И.Р. Черкашиной

COVID2019 Khabarovsk2 (2).jpg
25.02.2020

Presepsin as a New Marker for Early Detection Neonatal Sepsis in Al-Quwayiyah General Hospital Riyadh, KSA

Enas Sh. Khater1,2* and Taha M. Al-Hosiny3,4

1Department of Microbiology and Immunology, Faculty of Medicine, Benha University, Egypt.
2Microbiology Laboratory, Al-Quwayiyah General Hospital, Riyadh, KSA.
3Department of Pediatrics, Faculty of Medicine, Benha University, Egypt.
4Nursery Department, Al-Quwayiyah General Hospital, Riyadh, KSA.а
13.02.2020

Современный взгляд на биомаркеры воспаления у новорожденных детей

Т.Н. Войтович, Ю.А. Устинович, А.К. Дигоева
г. Минск, УО «Белорусский государственный медицинский университет»
05.11.2019

The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review

Lin Ruan1*, Guan-Yu Chen1, Zhen Liu1,2†, Yun Zhao1,2†, Guang-Yu Xu1,2†, Shu-Fang Li1,2†, Chun-Ni Li1,2†,
Lin-Shan Chen1,3† and Zheng Tao1,3†
05.11.2019

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis

Yutaka Kondo1†, Yutaka Umemura2†, Kei Hayashida3†, Yoshitaka Hara4, Morio Aihara5 and Kazuma Yamakawa6
10.10.2019

Роль биохимических маркеров воспаления у пациентов с нейтропенией после химиотерапии

Ю.Н. Дубинина1, В.О. Саржевский2, В.Я. Мельниченко2

1 Клиника амбулаторной онкологии и гематологии, ул. Молодогвардейская, д. 2, корп. 1, Москва, Российская Федерация, 121467
2 ФГБУ «Национальный медико-хирургический центр им. Н.И. Пиро-
гова», Минздрава России, ул. Нижняя Первомайская, д. 70, Москва,
Российская Федерация, 105203

10.10.2019

Sepsis diagnosis and monitoring – procalcitonin as standard, but what next?

Magdalena Mierzchała-Pasierb, Department of Medical
Biochemistry, Wroclaw Medical University,
10 Chalubinskiego St., 50-368 Wroclaw, Poland,
e-mail: magdalena.mierzchala-pasierb@umed.wroc.pl
16.09.2019

Пресепсин – биомаркер сепсиса и тяжелых инфекций: ранняя диагностика, прогноз, мониторинг

Вельков В.В., АО «ДИАКОН, г. Пущино, Московская область

09.09.2019

Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis

Seo Hee Yoon1, Eun Hwa Kim2, Ha Yan Kim2 and Jong Gyun Ahn1

* Correspondence: JGAHN@yuhs.ac
1Department of Pediatrics, Severance Children’s Hospital, Yonsei University
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article

19.08.2019

Clinical application of presepsin as diagnostic biomarker of infection: overview and updates

Emanuela Galliera*, Luca Massaccesi, Elena de Vecchi, Giuseppe Banfi
and Massimiliano M. Corsi Romanelli
31.07.2019

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis

Ying Zhu1,2
Xuehui Li1
Peiyan Guo1
Yuhan Chen3
Jiandong Li1
Tianzhu Tao4

1Department of Respiratory Medicine,
The Seventh Medical Center of PLA
General Hospital, Beijing, People’s
Republic of China;
2Department of Respiratory and Critical Care Medicine,
Shanghai East Hospital, Tongji University,
Shanghai, People’s Republic of China;
3Affiliated BaYi Children’s Hospital, The
Seventh Medical Center of PLA General
Hospital, Beijing, People’s Republic ofChina;
4Department of Anesthesiology,
Air Force Medical Center, PLA, Beijing,
People’s Republic of China
17.07.2019

Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis

Deepak P. Venugopalan , Gopalakrishna Pillai , Sajitha Krishnan
1. Internal Medicine, Aster Medcity, Kochi, IND 2. Internal Medicine, Amrita Institute of Medical
Sciences and Research Centre, Kochi, IND
 Corresponding author: Deepak P. Venugopalan, drdeepakvenugopalan@gmail.com
Disclosures can be found in Additional Information at the end of the article
15.04.2019

New Sepsis Marker-PRESEPSIN for early diagnosis and better prognosis of SEPSIS

06.03.2019

Септическое острое повреждение почек: ранняя комплексная диагностика сепсиса и гломерулярной и тубулярной дисфункции

Вельков В.В., АО «ДИАКОН», 2018
06.03.2019

Сепсис и острое повреждение почек — дорога с двухсторонним движением: значения биомаркеров

Вельков В.В., АО «ДИАКОН», 2018
19.02.2019

Пресепсин – эффективный биологический маркер для диагностики сепсиса и мониторинга системных инфекций

В.В. Вельков
Закрытое акционерное общество «Диакон», Московская область, г. Пущино.
23.01.2019

Can presepsin be used for screening invasive fungal infections?

Giuseppe Lippi 1 , Gianfranco Cervellin 2
1 Section of Clinical Biochemistry, University of Verona, Verona, Italy; 2 Emergency Department, University Hospital of Parma, Parma, Italy
Correspondence to: Prof. Giuseppe Lippi. Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy.
Email: giuseppe.lippi@univr.it
23.01.2019

Можно ли применять пресепсин для скрининга инвазивных грибковых инфекций?

Giuseppe Lippi, Gianfranco Cervellin. Can presepsin be used for screening invasive fungal infections?
Ann Transl Med. Accepted for publication Jan 16, 2019.
09.01.2019

Presepsin: A promising biomarker for the detection of bacterial infections

Mohammad Yousef Memar, Hossein Bnnazadeh Baghi
Immunology Research Center, Tabriz, Iran
27.11.2018

The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review

Lin Ruan 1* , Guan-Yu Chen 1 , Zhen Liu 1,2† , Yun Zhao 1,2† , Guang-Yu Xu 1,2† , Shu-Fang Li 1,2† , Chun-Ni Li 1,2† , Lin-Shan Chen 1,3† and Zheng Tao 1,3†
† Zhen Liu, Yun Zhao, Guang-Yu Xu, Shu-Fang Li, Chun-Ni Li, Lin-Shan Chen and Zheng Tao contributed equally to this work.
1 Departments of Anesthesiology, Guangxi Medical University Affiliated Tumor Hospital, Naning, Guangxi, China
Full list of author information is available at the end of the article
26.02.2018

Диагностическая точность пресепсина при неонатальном сепсисе: мета-анализ

Ioannis Bellos, Georgia Firou, Vasilios Pergialiotis, Nikolaos Thomakos, Despina N. Perrea, Georgios Daskalatis

Springer-Verlag GmbH Germany, part of Springer Nature 2018

20.02.2018

Пресепсин – новый перспективный маркер генерализованных бактериальных и грибковых инфекциий

26.01.2018

Prognostic value of presepsin in adult patients with sepsis: Systematic review and metaanalysis

Hyun Suk Yang1, Mina Hur2*, Ahram Yi2, Hanah Kim2, Seungho Lee3, Soo-Nyung Kim4
1 Department of Cardiovascular Medicine, Research Institute of Medical Science, Konkuk University School
of Medicine, Seoul, Korea, 2 Department of Laboratory Medicine, Konkuk University School of Medicine,
Seoul, Korea, 3 School of Public Health, Seoul National University, Seoul, Korea, 4 Department of Obstetrics
and Gynecology, Konkuk University School of Medicine, Seoul, Korea
* dearmina@hanmail.net
19.10.2017

The role of presepsin, c-reactive protein and procalcitonin as a marker of therapy response and prognosis for late onset neonatal sepsis in preterm neonates

Dalima AW Astrawinata 1 , Risma Kerina Kaban 2 , Rosalina Dewi Roeslani 3 , Erna Parmawati 4
1 Department of Clinical Pathology, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
2 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
3 Department of Pediatric, Faculty of Medicine University Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta
4 Department of Clinical Pathology Medical Specialty Program, Faculty of Medicine University Indonesia/Dr.Cipto
Mangunkusumo National General Hospital, Jakarta.
10.10.2017

Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta‐analysis

В статье приводится таблица разлиных маркеров сепсиса, их чувствительность и специфичность.

Yong Liu 1† , Jun‐huan Hou 2,3† , Qing Li 2,3 , Kui‐jun Chen 2,3 , Shu‐Nan Wang 4 and Jian‐min Wang 2,3*
† Yong Liu and Jun-huan Hou contributed equally to this work
2 Research Institute of Surgery, Daping Hospital, Third Military Medical
University, Chongqing 400042, People’s Republic of China
Full list of author information is available at the end of the article
14.08.2017

Новый высокочувствительный и высокоспецифичный маркер неонатального сепсиса - пресепсин

Д.Ж. БАТЫРБАЕВА, Б.А. РАМАЗАНОВА, А. БЕКНАЗАРОВА, Ж.С. АЛИБАЕВА, А.А. АБДРАИМОВА
А.Д. НУРАХОВА, Н.К. ИБРАЕВА, Р.С. БАТЫРХАНОВА
Казахский Национальный медицинский университет им. С.Д. Асфендиярова, НИИ ПФМ им. Б.А. Атшабарова,
Научная клинико-диагностическая лаборатория
19.06.2017

Пресепсин – новый биомаркер сепсиса и тяжелых инфекций: ранняя диагностика, прогноз, мониторинг

Вельков В.В., АО «ДИАКОН», г. Пущино, Московская область, 142290
16.05.2017

Использование биомаркёра «Пресепсин» для ранней и высокоспецифичной диагностики сепсиса

Руководства по клинической лабораторной диагностики.
Министерство Здравоохранения РФ.
Разработчик Вельков Василий Васильевич.
10.05.2017

Неонатальный сепсис: гемокультуры и биомаркеры – Проблемы и перспективы

В.В. Вельков
АО «ДИАКОН», г. Пущино, Московская область, РФ
17.01.2017

Пресепсин: ранняя диагностика сепсиса и тяжелых инфекционных осложнений

Подготовлено врачом лаборатории клинической иммунологии
НИИ СП им. Н.В. Склифосовского ДЗ г. Москвы
Салиной Нелли Николаевной
09.01.2017

Биологические маркеры в диагностике и лечении сепсиса (обзор литературы)

А. А. Звягин, В. С. Демидова, Г. В. Смирнов
ФГБУ «Институт хирургии им. А. В. Вишневского» Минздрава России; Россия, 117997, Москва, ул. Большая Серпуховская, 27
Контакты: Альфред Аркадьевич Звягин zvyagin@ixv.ru
09.01.2017

Опыт использования пресепсина (sCD14-ST) для диагностики бактериальных инфекций у новорожденных

Е.М. КОЗЛОВА, Г.Л. ШУНЬКИНА, Н.М. ЧУМАК, П.П. БОЛЬШАКОВ, ГБУЗ НО «Детская городская клиническая больница № 1
Приокского района г. Нижнего Новгорода»
26.12.2016

Diagnostic and Prognostic Value of Presepsin for Subclinical Chorioamnionitis in Pregnancies between 23-28 Week with Preterm Premature Rupture of the Membranes

Erbil Çakar¹, Şule Eren Çakar², Habibe Ayvacı Taşan¹, Deniz Karçaaltıncaba³, Mehmet Baki Şentürk¹,
Nermin Koç4, Ramazan Uluhan5

¹Department of Obstetrics and Gynecology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
²Deparment of Infectious Diseases, Ümraniye Training and Research Hospital, İstanbul, Turkey
³Department of Obstetrics and Gynecology, Gazi University School of Medicine, Ankara, Turkey
4Department of Pathology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
5Department of Clinical Microbiology, Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, İstanbul, Turkey
26.12.2016

Biomarkers of Sepsis

22.12.2016

Soluble CD14 subtype (SCD14-ST) presepsin levels in preterm newborns with RDS

N. Kultursay1 , S.Ergör 1, O. Altun Koroglu 1, M. Yalaz 1, M. Akisu 1
Division of Neonatology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey
29.09.2016

Пресепсин – маркер сепсиса

Кутепов Д.Б., д.м.н., врач-анестезиолог-реаниматолог,
зав. отд. экстракорпоральных методов лечения.
ФГБУ "Клиническая больница №1" Управления делами Президента РФ
(Волынская), Москва
07.09.2016

Пресепсин – ранний и надежный диагностический и прогностический маркер неонатального сепсиса

Jehan H Sabry1, Osama A Elfeky2, Akram E Elsadek3, Ahmed A Eldaly4.
1. Assistant Professor of Clinical & Chemical Pathology, Benha Faculty of Medicine, Egypt.
2. Professor of Pediatrics, Benha Faculty of Medicine, Egypt.
3. Lecturer of Pediatric, Benha Faculty of Medicine, Egypt.
4. Resident of Pediatrics, Ministry of Health, Egypt.
01.07.2016

Presepsin as an important diagnostic biomarker that differentiates sepsis from non-infectious SIRS in critical ill adult patients: A system review and meta-analysis

Dan Xie1 †, Kunpeng Hu2 †, Purun Lei3, Ying Xian1, Ying Wang1, Xiaogang Bi1, Kouxing Zhang1*
*Correspondence: Professor Kouxing Zhang, Department of General ICU of Lingnan Hospital, The Third Affiliated Hospital, Sun Yat-sen
University, Guangzhou, China,
18.05.2016

Биомаркеры неонатального сепсиса: С-реактивный белок, прокальцитонин, пресепсин

В.В. Вельков, к. б. н., директор по науке
АО «ДИАКОН», г. Пущино, Московская область
Biomarkers of neonatal sepsis: C-reactive protein, procalcitonin, presepsin
V. V. Velkov
DIAKON Co., Pushchino, Moscow region, Russia
13.04.2016

ПРЕСЕПСИН. Краткая информация.

Чем раньше диагностирован сепсис, тем раньше назначается эффективная терапия - тем выше выживаемость пациентов.
Проблемы, связанные с традиционными маркерами сепсиса.
08.10.2015

Presepsin Summary by Corrado Moiraghi

Marco Ulla Elisa Pizzolato Manuela Lucchiari
Maria Loiacono Flavia Soardo Daniela Forno
Fulvio Morello Enrico Lupia Corrado Moiraghi Giulio Mengozzi Stefania Battista
Corrado Moiraghi http://science.report/author/corrado-moiraghi/
23.07.2015

Использование биомаркера пресепсин для ранней и высокоспецифичной диагностики сепсиса

«Раны и раневые инфекции», Журнал им. проф. Б.М. Костючёнка
30.04.2015

Перспективы применения новых лабораторных методов в ранней диагностике сепсиса

Годило-Годлевский В.А., полковник вн. сл. в отставке, заместитель главного врача Медико-реабилитационного центра «Здоровье для вас», доцент кафедры факультативной терапии и пропедевтики внутренних болезней Государственной классической академии им. Маймонида, д.м.н., vg-god@rambler.ru
Гурбатова Т.Ю., начальник лабораторного отделения Главного клинического госпиталя МВД России;
Мельникова С.В., подполковник вн. сл., заместитель начальника лабораторного отделения – врач клинической лабораторной диагностики Главного клинического госпиталя МВД России, к.б.н.
20.04.2015

Role of presepsin for the evaluation of sepsis in the emergency department

Elisa Pizzolato*, Marco Ulla, Claudia Galluzzo, Manuela Lucchiari, Tilde Manetta,
Enrico Lupia, Giulio Mengozzi and Stefania Battista
14.04.2015

Presepsin: A Novel and Potential Diagnostic Biomarker for Sepsis

K V Ramana1,*, Venkata BharatKumar Pinnelli2, Sabitha Kandi3, Asha G2, Jayashankar CA4, Bhanuprakash5, Raghavendra DS2, Sanjeev D rao1
1Department of Microbiology, Prathima Institute of Medical sciences, Karimnagar, India 2Department of Biochemistry, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 3Department of Biochemistry, Chalmeda Anandarao Institute of Medical sciences, Karimnagar, India 4Department of General Medicine, Vydehi Institute of Medical sciences and Research center, Bengaluru, India 5Department of Dermatology, Vydehi Institute of Medical sciences and Research center, Bengaluru, India
*Corresponding author: ramana_20021@rediffmail.com
03.03.2015

Пресепсин: Биомаркер сепсиса. Краткая монография.

LSI Medience Corporation
13-4 Uchikanda 1-chome, Chiyoda-ku, Tokyo 101 - 8517, Japan
27.01.2015

Presepsin: solving a soluble (CD14) problem in sepsis?

Gareth L. Ackland
John R. Prowle
17.12.2014

Пресепсин — ранний и высокоэффективный маркер сепсиса

В. В. Вельков
ЗАО «ДИАКОН», г. Пущино, Московская область
13.10.2014

PreSEPSIN: The Sepsis Biomarker. A short monograph.

LSI Medience Corporation,
Mitsubishi Chemical Europe GmbH.
15.09.2014

Presepsin as a novel sepsis biomarker

Qi Zou, Wei Wen, Xin-chao Zhang
Emergency Medicine Department, Beijing Hospital, Beijing 100730, China
15.09.2014

A new marker for the diagnosis of sepsis: Presepsin

Mehmet Agilli, Irfan Sener, Fatih Yesildal, Tevfik Honca, Ibrahim Aydin, Emin Ozgur Akgul, Halil Yaman
Department of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey
11.09.2014

Комплексная лабораторная диагностика системных инфекций и сепсиса: С-реактивный белок, прокальцитонин, пресепсин

В.В. Вельков
11.09.2014

Пресепсин – ранний высокоэффективный биомаркер сепсиса. Краткий обзор

Вельков В.В., ЗАО «ДИАКОН», Пущино, Московская область, 142292.
10.09.2014

Пресепсин – ранний и высокоспецифичный маркер сепсиса: новые возможности

Вельков В.В.
ЗАО «ДИАКОН», г. Пущино, Московская область, 142292.
10.05.2014

Пресепсин: новый биомаркер для прогнозирования и диагностики сепсиса

Иошиказу Окамура, Ральф Томэ
Департамент исследований и разработок Митсубиси Кемикл Медиенс Корпорэйшн, Япония.

Яндекс.Метрика